Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 293

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 293
---
 the FDA, including, among
other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion
and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications
or other labeling claims are subject to prior FDA review and approval. There also are continuing annual user fee requirements for any
marketed products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications
with clinical data.

Employees
and Human Capital Resources

As
of February 4th, 2025, we had 5 part-time employees  None of our employees is represented by a labor union or are covered
by a collective bargaining agreement. We consider our relationship with our employees to be satisfactory. In addition, we utilize the
services of contractors and part-time outside consultants to support our organization’s needs. We expect to continue to build our
team to ensure we can effectively execute our development plans.

18

 Legal
Proceedings

There
are no material proceedings to which any director or officer, or any associate of any such director or officer, is a party that is adverse
to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries. No director or executive officer
has been a director or executive officer of any business which has filed a bankruptcy petition or had a bankruptcy petition filed against
it during the past ten years. No current director or executive officer has been convicted of a criminal offense or is the subject of
a pending criminal proceeding during the past ten years. No current director or executive officer has been the subject of any order,
judgment or decree of any court permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any
type of business, securities or banking activities during the past ten years. No current director or officer has been found by a court
to have violated a federal or state securities or commodities law during the past ten years. From time to time, we may be named in claims
arising in the ordinary course of business.

We
anticipate that we will expend significant financial and managerial resources in the defense of our intellectual property rights in the
future if we believe that our rights have been violated. We also anticipate that we will expend significant financial and managerial
resources to defend against claims that our products and services infringe upon the intellectual property rights of third parties.

Corporation
Information

We
were organized as a